2011 Press Releases
11/16/2011   Genzyme and Cystic Fibrosis Foundation Therapeutics Announce Collaboration to Discover New CF Drugs
11/02/2011   CF Foundation Issues Statement on The New England Journal of Medicine Study Showing Evidence of Success in Treating Underlying Cause of CF
11/01/2011   Anaheim to Host World’s Largest Gathering on Cystic Fibrosis Research and Care
07/06/2011   Cystic Fibrosis Foundation Announces Aptalis Pharma as Title Sponsor of its Premier Cycling Event for 2011
06/22/2011   Teens Lobby Congress to Raise Awareness of Cystic Fibrosis
06/09/2011   Phase 2 Study of Two Potential CF Therapies — VX-770 and VX-809 — Shows Promising Results in Patients with Most Common Mutation
05/18/2011   Cystic Fibrosis Foundation Launches “Walk Weekend”– More Than 200 Great Strides Fundraisers Scheduled for May 21-22
03/19/2011   U.S. Senator Ron Wyden and U.S. Representatives Edward Markey and Cliff Stearns Honored for Leadership on Behalf of People with Cystic Fibrosis
02/23/2011   Phase 3 Study of VX-770 Shows Marked Improvement in Lung Function Among People with Cystic Fibrosis with G551D Mutation